WallStreetZenWallStreetZen

NASDAQ: WVE
Wave Life Sciences Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for WVE

Based on 8 analysts offering 12 month price targets for Wave Life Sciences Ltd

Min Forecast
$10.00+4.17%
Avg Forecast
$18.00+87.5%
Max Forecast
$24.00+150%

Should I buy or sell WVE stock?

Based on 8 analysts offering ratings for Wave Life Sciences Ltd.

Strong Buy
Strong Buy
4 analysts 50%
Buy
4 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although WVE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates WVE as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their WVE stock forecasts and price targets.

WVE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-04
lockedlocked$00.00+00.00%2025-07-31
lockedlocked$00.00+00.00%2025-07-28
lockedlocked$00.00+00.00%2025-07-16
lockedlocked$00.00+00.00%2025-06-23
Raymond James
Top 41%
60
BuyAssumes$14.00+45.83%2025-06-11
Cantor Fitzgerald
Top 16%
85
Strong BuyInitiates Coverage On$10.00+4.17%2025-04-29
HC Wainwright & Co.
Top 1%
100
BuyReiterates$22.00+129.17%2025-03-26

1 of 1

Forecast return on equity

Is WVE forecast to generate an efficient return?

Company
-92.94%
Industry
122.1%
Market
-51.71%
WVE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is WVE forecast to generate an efficient return on assets?

Company
-51.29%
Industry
45.93%
WVE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

WVE earnings per share forecast

What is WVE's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$1.17
Avg 2 year Forecast
-$1.26
Avg 3 year Forecast
-$0.89

WVE revenue forecast

What is WVE's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$42.7M-54.52%
Avg 2 year Forecast
$55.4M-40.99%
Avg 3 year Forecast
$119.6M+27.34%
WVE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WVE revenue growth forecast

How is WVE forecast to perform vs Biotechnology companies and vs the US market?

Company
5.96%
Industry
83.25%
Market
10.49%
WVE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WVE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WVE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WVE$9.60$18.00+87.50%Strong Buy
ARDX$6.36$11.57+81.93%Buy
EWTX$14.35$38.17+165.97%Buy
VRDN$18.38$35.00+90.42%Buy
TVTX$17.50$35.56+103.18%Strong Buy
View Top Biotech Stocks

Wave Life Sciences Stock Forecast FAQ

Is Wave Life Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: WVE) stock is to Strong Buy WVE stock.

Out of 8 analysts, 4 (50%) are recommending WVE as a Strong Buy, 4 (50%) are recommending WVE as a Buy, 0 (0%) are recommending WVE as a Hold, 0 (0%) are recommending WVE as a Sell, and 0 (0%) are recommending WVE as a Strong Sell.

If you're new to stock investing, here's how to buy Wave Life Sciences stock.

What is WVE's earnings growth forecast for 2025-2027?

(NASDAQ: WVE) Wave Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.8%.

Wave Life Sciences's earnings in 2025 is -$129,874,000.On average, 9 Wall Street analysts forecast WVE's earnings for 2025 to be -$186,544,447, with the lowest WVE earnings forecast at -$225,979,453, and the highest WVE earnings forecast at -$154,366,246. On average, 9 Wall Street analysts forecast WVE's earnings for 2026 to be -$201,217,198, with the lowest WVE earnings forecast at -$281,678,614, and the highest WVE earnings forecast at -$167,097,483.

In 2027, WVE is forecast to generate -$142,319,313 in earnings, with the lowest earnings forecast at -$276,904,400 and the highest earnings forecast at -$35,010,901.

What is WVE's revenue growth forecast for 2025-2027?

(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 5.96% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.49%.

Wave Life Sciences's revenue in 2025 is $93,946,000.On average, 8 Wall Street analysts forecast WVE's revenue for 2025 to be $6,798,798,732, with the lowest WVE revenue forecast at $2,843,840,020, and the highest WVE revenue forecast at $10,036,988,812. On average, 6 Wall Street analysts forecast WVE's revenue for 2026 to be $8,822,906,243, with the lowest WVE revenue forecast at $3,731,843,787, and the highest WVE revenue forecast at $14,688,664,458.

In 2027, WVE is forecast to generate $19,038,609,792 in revenue, with the lowest revenue forecast at $5,251,635,180 and the highest revenue forecast at $44,241,047,880.

What is WVE's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: WVE) forecast ROA is -51.29%, which is lower than the forecast US Biotechnology industry average of 45.93%.

What is WVE's Price Target?

According to 8 Wall Street analysts that have issued a 1 year WVE price target, the average WVE price target is $18.00, with the highest WVE stock price forecast at $24.00 and the lowest WVE stock price forecast at $10.00.

On average, Wall Street analysts predict that Wave Life Sciences's share price could reach $18.00 by Aug 4, 2026. The average Wave Life Sciences stock price prediction forecasts a potential upside of 87.5% from the current WVE share price of $9.60.

What is WVE's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: WVE) Wave Life Sciences's current Earnings Per Share (EPS) is -$0.80. On average, analysts forecast that WVE's EPS will be -$1.17 for 2025, with the lowest EPS forecast at -$1.42, and the highest EPS forecast at -$0.97. On average, analysts forecast that WVE's EPS will be -$1.26 for 2026, with the lowest EPS forecast at -$1.77, and the highest EPS forecast at -$1.05. In 2027, WVE's EPS is forecast to hit -$0.89 (min: -$1.74, max: -$0.22).

What is WVE's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: WVE) forecast ROE is -92.94%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.